Market Research Analysis

[persistencemarketresearchre-blog]

Hyperpigmentation Treatment Market

Hyperpigmentation refers to darkening of the skin characterized by excess production or accumulation of melanin, a pigment which primarily determines the skin color. Hyperpigmentation can be a diffuse (spread over large area of a body) or focal (restricted to certain body part) and can affect any part of the body, mostly face, hands and chest. Hyperpigmentation is clinically harmless condition but it can be of concern cosmetically. Some of the common causes of hyperpigmentation include inflammation, skin injury, phytophotodermatitis (photo toxicity), lentigines, melisma, melanoma or even it can be a drug-induced condition. Hyperpigmentation can be treated by two approaches viz. Drug/Pharmacological treatment and Cosmetic treatment. Expanding aging population and increasing incidence of skin disorders are the primary contributors to the growth of global hyperpigmentation treatment market. Moreover, growing demand for the skin lightening, upgraded lifestyle, global climate changes and global warming, rising number of smokers, increasing disposable income can drive the global hyperpigmentation treatment market. In spite of this stringent regulatory policies and safety concerns associated with the use of cosmetic products for skin lightening can hinder the growth of global hyperpigmentation treatment market.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/9983 The global hyperpigmentation treatment market has been segmented on the basis of treatment type, retail sales channels and geography. Based on treatment type, the global hyperpigmentation treatment market is divided into following:Pharmacological therapySynthetic OriginHydroquinone Topical Corticoids (steroids) Azelaic acid Ascorbic acid (Vitamin C) Natural OriginKojik acid Liquorice extract Citrus Extracts Non-pharmacological/Cosmetic TherapyLaser treatment Chemical peels and bleach Microdermabrasion Skin grafting/Plastic surgery Based on retail sales channels, the global hyperpigmentation treatment market is divided into following: Skin Clinics Drug and Cosmetic Stores Hypermarkets and Supermarkets The global hyperpigmentation treatment market is expected to grow with a significant CAGR due to availability of various treatment options and rapid adoption of new technologies. The non-pharmacological or cosmetic therapy sub-segment is expected to contribute more to the global hyperpigmentation market owing to their quick results. Customer demand for the skin brightening products is expected to increase during the forecast period of 2016-2021 due to increasing aesthetic concern. Geographically, the global hyperpigmentation treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.  North America will continue to hold the largest share in global hyperpigmentation treatment market because of rising aging demographics. Asia Pacific is expected to be the most lucrative region for the new entrants in the global hyperpigmentation treatment market.

Request for TOC@  https://www.persistencemarketresearch.com/toc/9983

Some of the major players in the global hyperpigmentation treatment market include Biocosmetic Research Labs, Episciences, Inc., Vivier Pharma, Inc., La Roche-Posay, Pierre Fabre Dermo Cosmetique, Bayer AG, Alvogen, Inc., Allergan, Inc., Obagi Medical Products Inc., SkinCeuticals International, L’oréal Paris and others.

[persistencemarketresearchre-blog]

Growth Hormone Deficiency Treatment Market

Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. Though the exact cause of growth hormone deficiency is obscure, it is considered to be of genetic origin or also it can develop after a trauma, brain injury, due to pituitary tumors etc. Children with growth hormone deficiency show retarded growth and sometimes delayed puberty. Symptoms of growth hormone deficiency vary among adults and children. The predominant symptom in children is that the child is abnormally shorter than other children of his age with or without compromise in the cognitive intelligence while in adults, growth hormone deficiency may lead to fatigue, tiredness, anxiety and depression. Growth hormone deficiency is treated with growth hormone injections on daily or weekly basis although the effects of therapy starts showing after 2-3 months of therapy.The primary factor contributing to the growth of global growth hormone deficiency treatment market is increasing incidence of growth hormone deficiency syndrome. Several other factors which may cause the global growth hormone deficiency market to grow include changing lifestyle, prevalence of other genetic disorders and incidence of GHD in adults. However, high cost of treatment will always remain the major restraint for global growth hormone deficiency treatment market.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/9962

The global growth hormone deficiency treatment market has been segmented on the basis of treatment type, end user, retail sales channels and geography.Based on treatment type, the global hyperpigmentation treatment market is divided into following:

Pharmacological therapy

Recombinant Human Growth Hormone

Human pituitary gland extracts

Surgery

Based on end user, the global hyperpigmentation treatment market is divided into following:

Hospitals

Clinics

Home care settings

Based on retail sales channels, the global hyperpigmentation treatment market is divided into following:

Pharmacy and drugstores

Hospital pharmacy

Online drug stores/email prescription stores

Surgeries in treatment of growth hormone deficiency treatment are rarely performed. Recombinant human growth hormone sub-segment of pharmacological therapy treatment type is expected to hold major share in the global growth hormone deficiency treatment market due to increased patient compliance. Home care settings’ end user segment occupies significant proportion of global growth hormone deficiency treatment market owing to the nature of a therapy requiring daily dosage administration. Introduction of new medicines such as Saizen solution is anticipated to expand the market growth of global growth hormone deficiency treatment market over the forecast period of 2016-2026.  Geographically, the global growth hormone deficiency treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.  North America is expected to contribute largest market share in global growth hormone deficiency treatment market followed by Europe. Emerging markets such as China, India, and Brazil are expected to present good opportunity for growth hormone deficiency treatment market due to entrance of key players into the market.

Request for TOC@ https://www.persistencemarketresearch.com/toc/9962

Some of the major players in the global growth hormone deficiency treatment market include Sandoz International GmbH, Sanofi Aventis, Pfizer, Novo Nordisk A/S, Teva Pharmaceutical Industries Limited, Ranbaxy, EMD Serono, Inc., Sun Pharmaceutical Industries Ltd., Eli Lilly and Company and others.

[persistencemarketresearchre-blog]

North America Market Study on Toxicology Laboratories: Increasing Usage of Toxicology Testing Services in Crime Investigation is Expected to Drive the Growth of Toxicology Laboratories

Persistence Market Research delivers key insights on the North America Toxicology Laboratories Market in its latest outlook titled “North America Market Study on Toxicology Laboratories: Increasing Usage of Toxicology Testing Services in Crime Investigation is Expected to Drive the Growth of Toxicology Laboratories”.The North America Toxicology Laboratories market is expected to reach US$ 198.2 Mn by the end of 2022 at a CAGR of 11.1% during the forecast period. On the basis of drug class, the North America toxicology laboratories market is segmented into alcohol, amphetamines, barbiturates, benzodiazepines, opiates/opioids, tricyclic antidepressants, and Z-Drugs. Weak regulatory control on prescription drugs with regard to over-the-counter purchases has been resulting in increased substance abuse and for amphetamines in particular. This increased consumption is fueling the demand for drug toxicology testing of amphetamines across the U.S. Amphetamines drug toxicity testing segment has been estimated to contribute highest in terms of revenue, accounting for 27.7% of the total toxicology laboratories market share in 2015. The opiate/opioids drug class segment has been estimated to be the fastest-growing segment of the North America toxicology laboratories market, registering a CAGR of 13.3% during the forecast period.North America toxicology laboratories market is majorly driven by increasing abuse of controlled substances and drugs, increased expenditure by the government agencies on toxicity testing to control consumption of illegal drugs, and favorable reimbursement policies for conducting toxicity testing across workplaces. Additionally, commercial availability of high-end drug testing instruments, and economical, rapid, and effective methods to conduct drug testing is expected to drive the growth of the North America toxicology laboratories market. However, the introduction of point-of-care toxicology testing devices, longer wait time for sample testing in laboratories, and limited efficacy of conventional techniques are factors likely to impede the growth of the North America toxicology laboratories market over the forecast period.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/9707 On the basis of sample type, the North America toxicology laboratories market is segmented into, urine, blood, hair, and oral fluid type segments. Urinalysis is one the most prominent techniques used to analyze toxicity in urine samples. This is due to its non-invasive approach, which promotes application in analyzing alcohol, opioids, and amphetamine drug traces and levels in samples. The urine sample segment has been estimated to account for ~62% revenue share in overall toxicology laboratories market in 2015.The U.S. toxicology laboratories market has been estimated to account for over 83% revenue share of the overall North America toxicology laboratories market in 2015. This is attributed to substantially high levels of drug abuse and unregulated prescribing patterns for hallucination drugs such as amphetamines, barbiturates, benzodiazepines, tricyclic antidepressants, and Z Drugs.

Request for Methodology@  https://www.persistencemarketresearch.com/methodology/9707

The report begins with an overview of the North America toxicology laboratories market in terms of value, and a detailed analysis of key trends, drivers, and restraints, and opportunities, which are the main factors impelling growth of the toxicology laboratories market are covered in this section. Impact analysis of key growth drivers and restraints based on the weighted average of each of these factors in a model-based approach is included in the report. The report provides in-depth information on the potential scope of high-end confirmatory testing instruments to provide clients with crystal clear decision-making insights.

[persistencemarketresearchre-blog]

Anti-inflammatory drugs segment expected to reach a CAGR of 4.2% during the projected period

The Crohn’s & Colitis Foundation of America (CCFA) stated that over 1 Million Americans were diagnosed with Crohn's & ulcerative colitis disorders, with most of them aged above 30. Growing occurrence of Crohn's disease has triggered a robust demand for its therapeutics. A survey conducted by the US Center for Disease Control (CDC) has revealed that the incidence rate of Crohn's disease in the country is 3.1 to 14.6 new cases per 100,000 population annually. The disease is highly prevalent in developed countries, especially in individuals who smoke.  According to a study conducted by Persistence Market Research (PMR), demand for anti-inflammatory drugs and biologics for treating Crohn's disease will gain traction in the near future. PMR forecasts that the global market for Crohn's disease is set to reach US$ 4,474.8 Million by 2024-end, growing at a CAGR of 3% during the assessment period.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/9665

Increasing demand for biologics for treating bowel disorders such as ulcerative collates and Crohn's disease is propelling the overall growth of Crohn's disease market. Moreover, drug manufacturers are actively focusing on advanced products having higher efficiency. The growing patient population is an additional factor expected to influence the market growth between 2016 and 2024. Therefore, higher utilization and preference for biologics and anti-inflammatory drug therapies coupled with the surging popularity of biosimilars is expected to play an important role in shaping the market for the future.BottlenecksThe high cost of treatment will remain as a major impediment for the market. Further, the patient expiry of blockbuster drugs and lack of early diagnosis particularly in third world countries are some of the other hindrances that are likely to inhibit the market growth during the forecast period.Major TrendsHigher preference for symptomatic therapeutic and drugs over surgeries, better treatment management of inflammatory bowel diseases, the arrival of enhanced drugs in the market owing to healthier investments in R&D programs are some of the key trends governing the market.Market OverviewWhile biologics will continue to remain the most preferred drug type amongst both healthcare professionals and patients, the demand for anti-inflammatory drugs will also witness a rampant acceleration during the forecast period. Based on drug type, the anti-inflammatory drug segment is projected to reach a market valuation of US$ 1,095.9 Million by end of the assessment period.Based on distribution channel, the hospital pharmacies will continue to be the leading segment of the market over the forecast period. Whereas, the retail pharmacies segment is projected to exhibit the highest growth, reaching a market valuation of US$ 1,470.2 Million by 2024.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/9665

PMR’s findings based on regional assessment suggest that the Crohn's disease market in North America will continue to lead the pack during the forecast period. The region’s market is expected to value US$ 3,149.8 Million over 2014. However, Asia-Pacific is expected to witness the highest CAGR over the forecast period. The APAC market is projected to create an absolute $ opportunity of US$ 13.2 Million in 2017 over 2016.

[persistencemarketresearchre-blog]

Ether Carboxylates Market

Ether carboxylate is one of the major sub-types of a carboxylate which is produced from the reaction of ethoxylated alcohols with sodium chloracetate. Its manufacturing process involves etherification where a carboxyl group-containing compound and a hydroxyl group-containing compound are reacted in an aqueous medium with the help of a rare earth element containing catalyst. The carboxyl group containing compound present in the reaction is one compound which is selected from carboxyl group containing epoxy compounds as well as unsaturated carboxyl group containing compounds. Ether carboxylates are widely used in personal care products, surfactants, admixtures applied in the construction as well as serve as the vital component of superplasticizers. As surfactants, ether carboxylate produces an ultralow interfacial tension (IFT) under high temperature and high salinity conditions. Their consumption in the textile industry is based on their electrolyte, alkali, and hard water stability as well as their good wetting and detergent properties. As compared to cold process soaps, ether carboxylates are less sensitive to hard water and more soluble in water. In addition, they impart good wetting and foam stabilizing properties as well as provide creaminess and mildness in the finished products. Owing to their property of being substantive to hair and skin, ether carboxylate exhibits a conditioned feeling to the human body. When combined with alkyl ether sulfates such as sodium laureth sulfate, they are used for manufacturing shampoos on account of their compatibility with cationic ingredients. The global market for ether carboxylate has been witnessing a significant increase on account of growth of its application industries such as personal care and surfactants. Ether carboxylate shares a wide application scope in various industries such as soaps, detergents, textiles, shampoos, and plasticizers among others. In addition, bio-based surfactants has emerged as one of the major opportunities for the growth of the surfactant industry due to growing awareness among consumers towards eco-friendly products which in turn has contributed towards the growing demand for ether carboxylate in surfactants. Major applications of ether carboxylate-based surfactants include detergents, pharmaceuticals, textile and personal care among others

. Request for sample reports@ https://www.persistencemarketresearch.com/samples/4292

Other applications of ether carboxylate include the manufacturing of plasticizers. The market for ether carboxylate in plasticizer has been witnessing significant growth on account of emerging economies and changing lifestyles. In addition, rising environmental awareness coupled with increasing legal provisions have been serving as catalysts for the plasticizers market in certain emerging economies such as India, China, Russia and Brazil. While matured regions such as North America and Europe accounted for the highest demand for ether carboxylate due to presence of vast and skin care and hair care industries, emerging regions such as Asia Pacific are anticipated to witness the fastest growth over the next few years on account of vast textile industries in economies such as China as well as growing demand for personal care products. Various factors such as rising awareness regarding healthy hair and skin among consumers as well as changing lifestyles are expected to boost the demand for personal care products which in turn is anticipated to contribute towards the demand for ether carboxylate. Growing demand for personal care products such as skin care and hair care on account of increasing awareness for healthy skin and hair is anticipated to be on the major factors driving the market for ether carboxylate. However, fluctuating prices of key feedstock materials has been major concern for the manufacturers and is expected to limit the growth of the market. Focus on commercializing and developing cost-effective bio-based surfactants using ether carboxylate is anticipated to provide new opportunities for the growth of the market. 

Request for TOC@ https://www.persistencemarketresearch.com/toc/4292

BASF SE, Huntsman Corporation, KAO Corporation, and Nippon Shokubai Co., Ltd. are some of the key manufacturers of ether carboxylate present in the market.

[persistencemarketresearchre-blog]

Patient Handling Equipments Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2015 to 2021

Patient handling comprises the lifting, lowering, holding, pushing, or pulling of patients. Patient handling equipments are mobility, disability, and rehabilitation equipments specifically designed to provide comfort and quality of sleep to hospitalized patients and cater to their other healthcare needs. These medical equipment provide flexibility and relaxation to the patient. The increasing prevalence of lifestyle diseases and the growing elderly population are the major driving factors for the patient handling equipments market in Europe. Healthcare organizations are increasing the adoption of patient handling equipment to avoid the injuries often caused by manual handling. Patient handling tasks includes transferring, lifting, and repositioning (turning patients in bed, giving patients baths on the bed, patient dressings, etc.) Patient handling equipment include stretchers, I.V. poles and accessories, operating table pads, armboard pads, wheelchair, medical beds, and scooters. Stretchers, wheelchairs, and scooters are used for moving patients who require medical care. Medical beds allow patients to change position for comfort and provide a comfortable sleep environment. The patient handling equipment market in Europe is segmented based on the type of care, end user, product, and accessories. Based on the type of care, the market covers bariatric care, prevention from accidental falls, critical care, wound care, and others. Based on the type of product, the market comprises wheelchairs and scooters, medical beds, bathroom safety supplies, mechanical lifting equipments and nonmechanical lifting equipments, ambulatory aids, and others. The wheelchair segment is further subdivided into manual wheelchairs and powered wheelchairs. The medical beds segment includes curative care beds, psychiatric care beds, long-term care beds, and others. Based on the accessories, the market covers lifting accessories, transfer accessories, evacuation accessories, stretcher accessories, hospital-bed accessories, and others. Based on end users, the market comprises hospitals, nursing homes, clinics, elderly care facilities, home care facilities, academic research institutes, and others. The medical bed segment accounts for the largest share of the patient handling equipment market in Europe. 

Request for sample reports@ https://www.persistencemarketresearch.com/samples/4281

The U.K. has the largest market for patient handling equipment in Europe, followed by Germany. This is due to increasing prevalence of lifestyle diseases, rising demand for patient handling equipments, and various initiatives taken by government programs to promote safe patient handling. Also, disabilities from noncommunicable diseases, a growing aging population, increased healthcare expenditure, and improved healthcare infrastructure support the growth of the patient handling equipment market in the U.K.A growing geriatric population, the increasing prevalence of chronic diseases, technological advances, an increasing number of healthcare establishments, and demand for better healthcare services are major drivers for the patient handling equipments market in Europe. Moreover, an increasing number of hospitalization cases, rising healthcare expenditure, and growing need for multifunctional and affordable medical equipment are other factors supporting the growth of the patient handling equipment market in Europe. However, a dearth of trained medical professionals to handle patients in critical condition obstructs the growth of the market.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/4281

Increasing numbers of mergers and acquisitions, a rise in the number of collaborations and partnerships, and rapid product launches are some of the latest trends in the patient handling equipments market in Europe. Some of the major companies operating in the market are Linet, Inc., Handicare, Inc., Benmor Medical Ltd, ArjoHuntleigh, Inc., Spectra Care Group, Etac Ltd., Guldmann, Inc., Stiegelmeyer, Inc., Mangar International Ltd., and Sidhil Ltd.

[persistencemarketresearchre-blog]

The global immune health supplements market is expected to witness substantial growth during the forecast period.

The global

immune health supplements market

is expected to expand at a CAGR of 7.0% in terms of value during the eight year period between 2017 and 2025. According to the new report published by Persistence Market Research titled, “Immune Health Supplements Market: Global Industry Analysis (2012–2016) & Forecast (2017–2025),” North America is the largest market for immune health supplements, attributable to a rise in the number of health conscious consumers. Consumers in this region are willing to pay more for products that are organic, GMO-free, and vitamin and mineral fortified, thus creating lucrative market opportunities for immune health supplements manufacturers.Global Immune Health Supplements Market: Trends

Increasing availability of immune health supplements across hypermarkets and drug stores

Growing demand for natural products and expanded focus towards preventive care

Investments by health and wellness companies towards R&D

Customization for specific regions

Global e-Commerce growth

Focus by key market players on broadening the customer base and on new product development

Global Immune Health Supplements Market: Forecast by RegionThe five key geographies of North America, Latin America, Europe, APAC and MEA have been covered in this report. North America is estimated to account for around 36.7% share in terms of value in the global immune health supplements market in 2017. The market in APAC is projected to witness rapid growth and register a CAGR of 8.3% over the forecast period, owing to changing lifestyles of people, increasing urbanization, along with the growing health consciousness among the population. The rapidly growing aging population along with the prevalence of chronic diseases is expected to create profitable market opportunities for immune health supplements manufacturers in the aforementioned regions during the forecast period.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/5852

Global Immune Health Supplements Market: Forecast by Ingredient TypeOn the basis of ingredient type, the global immune health supplements market is segmented into vitamins, minerals, herbal/botanical extracts, amino acids, probiotics, Omega-3 fatty acids, and others. By ingredient type, the vitamins segment is expected to gain traction in the coming years due to the antioxidant feature of vitamins that helps the body fight against infections, along with supporting biochemical reactions in the immune system. This segment accounts for a high revenue share in the global immune health supplements market, and is expected to register a substantial growth rate during the forecast period. Furthermore, with increasing concerns about the side effects of chemicals and synthetic additives used in food and beverages, consumers are inclined towards natural alternatives. This particular factor is improving the demand for customized products or natural alternatives for established variants in the market.Global Immune Health Supplements Market: Forecast by FormSoft gels/pills, tablets, powder and liquid are the segments by form in the global immune health supplements market. The soft gels/pills segment is expected to show a relatively high market attractiveness index over the forecast period. The soft gels/pills segment is expected to register a CAGR of 6.7% during the forecast period. This segment is estimated to account for a relatively high value share of 38.1% by 2017 end.Global Immune Health Supplements Market: Forecast by Sales ChannelSegmentation by sales channel includes online retailing and store based retailing. Store based retailing is sub-segmented into hypermarket/supermarket, pharmacies & drug stores, independent health stores and others. The store based retailing segment is expected to register a CAGR of 6.7% during the forecast period. The segment is estimated to account for a relatively high value share of 69.7% by 2017 end.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/5852

Global Immune Health Supplements Market: Forecast by Source TypeBy source type, the global market is segmented into plant-based and animal-based source types. With more than 60% revenue share, the plant-based segment is expected to lead the global market and register a CAGR of 7.4% during the forecast period. On the other hand, the animal-based segment is likely to grab just about 36.8% revenue share of the global immune health supplements market.

[persistencemarketresearchre-blog]

In addition, the surgical and respirator mask market in New Zealand was valued at US$ 30.9 million in 2014 and is expected to reach up to US$ 38.2 million by 2021.

According to a new market report published by Persistence Market Research, titled “Australia and New Zealand Market Study on Surgical and Respirator Masks: Australia to Witness Highest Growth by 2021”, the surgical and respiratory mask market in Australia and New Zealand is expected to reach US$137.8 Mn by the end of 2015 and is anticipated to expand at a CAGR of 3.3% from 2015 to 2021, to reach US$167.7 Mn by 2021.Surgical and respiratory masks can be defined as medical devices that are used to cover mouth, nose and chin, in order to protect the healthcare professionals and patients against droplets, including large respiratory particles. Surgical and respiratory masks are mainly used in hospitals and day surgery centres by physicians, independent dental surgeons, veterinary surgeons and life science professionals.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/5684

Presently, the surgical and respiratory mask market in Australia and New Zealand is mainly driven by factors such as the increasing number of surgical procedures, rising health and hygiene concerns, and product innovation. However, factors such as logistics and distribution channel formulation saturated the market with unmet consumer needs, limited product availability, and competition between large multinational and local players are expected to restrain the growth of the market. The surgical and respiratory mask market in Australia and New Zealand is anticipated to expand at a CAGR of 3.3 % from 2015 to 2021, to reach US$ 167.7 Mn by 2021.The Australia surgical and respirator mask market is expected to dominate the entire market in Australia and New Zealand by the end of 2015. The market is expected to be valued atUS$ 106.2 Mn by the end of 2015. The surgical and respirator mask market in New Zealand is expected to be valued at US$ 31.6 Man by the end of 2015 and is expected to expand at a CAGR of 3.2% during the forecast period. 

Request for Methodology@     https://www.persistencemarketresearch.com/methodology/5684

[persistencemarketresearchre-blog]

Mammography Equipment Market: Drivers, restraints, and challenges shaping the Mammography Equipment market dynamics

Breast cancer is formed in the tissues of breast. Some of the common symptoms for breast cancer are change in breast shape, lump in breast and dimpling of skin. Obesity, lack of physical exercise, hormone replacement therapy during menopause and drinking alcohol are some of the risk factors associated with breast cancer. Ductal carcinoma is the most common type of breast cancer which occurs in the lining of the milk ducts. Another type of breast cancer is lobular carcinoma. It occurs in the lobules. Mammography is a technique used for screening and diagnosis of breast with the help of device known as mammogram. Mammography includes minimal radiation exposure which helps in protecting patients from harmful radiation side effects. The main purpose of mammography is to detect breast cancer and tumor in women. Mammogram also helps in visualization of normal and abnormal structures within the breast. Screening test is used when symptoms of breast cancer or tumor are not available whereas, diagnostics test is done to detect the causes of specific symptoms. These tests help in early treatment of disease and also help in curing diseases. Mammography helps in reduction of death rate and disability occurred due to cancer and provides better options for treatment. Mammogram helps in providing accurate results for cancer diagnosis. It also helps healthcare professionals to identity whether a lump in the breast is a gland or harmless cyst. Digital radiography mammography equipment and film-screen mammography equipment are two types of mammography equipments.North America followed by Europe are dominating the global mammography equipment market due to early adoption of new technology and rising incidence of breast cancer in these regions. The U.S. is dominating the North American mammography equipment market due to technological advancements and increasing reimbursements for full-field digital mammography. Asia is expected to show high growth rate due to rising incidence of cancer. Some of the key driving forces for the growth of mammography equipments market in emerging countries are rising government initiatives for promotion of breast health screening and improved healthcare infrastructure. In recent time there is increased use of mammography equipment due to rising prevalence of breast cancer in women. Technological advancements in digital radiography such as breast tomosynthesis and contrast-enhanced mammography, and increasing uses of 3D mammography are some of the key factors driving the growth of the global mammography equipment market. In addition, rising awareness for breast cancer and growing aging population are also fuelling the growth of the global mammography equipment market. However, limited reimbursement for mammography equipment is restraining the growth of the global mammography equipment market. 

Request for sample reports@ https://www.persistencemarketresearch.com/samples/3578 Innovation in Low cost mammography equipment would develop an opportunity for the global mammography equipment market. Increasing demand for full-field digital mammography and hybrid imaging are some of the trends for the global mammography equipment market. In addition, increasing magnetic resonance imaging with mammography is also a trend in the global mammography equipment market. Some of the major companies operating in the global mammography equipment market are Hologic, Inc., GE Healthcare, Analogic Corporation, Fujifilm Holdings Corporation, Siemens Healthcare and Philips Healthcare.

[persistencemarketresearchre-blog]

Wound Debridement Products Market: Analysis of business strategies of the top players

Wound debridement is a procedure to remove contaminated, dead tissue and foreign substance from a wound. Wound debridement product helps to reduce various types of microbes, toxins and other foreign material that inhibit healing of the wound. On the basis of method of debridement, wound debridement products market can be segmented into selective methods and non-selective methods. Selective methods include larvae debridement therapy or bio-surgical debridement, enzymatic or chemical debridement and autolytic debridement. Non-selective methods include mechanical debridement, ultrasound and sharp and surgical debridement. On the basis of type of wound, wound debridement products market can be segmented into acute wounds, burn wounds and chronic wounds. Acute wounds include surgical wounds, traumatic wounds, abrasions, necrotizing fasciitis, lacerations, contusions and toxic epidermal necrolysis. Burn wounds include chemical burns, electrical burns, flash burns, radiation burns and thermal burns. Chronic wounds include diabetic ulcers, venous ulcers and pressure ulcers. Process of wound care includes preparation, controlling bleeding, irrigation and cleaning, closure and infection control. Process of wound healing includes stages such as inflammatory response, coagulation cascade, vasodilation, cellular activity, debridement or cell growth and healing, scarring and fetal wound healing. North America, followed by Europe, has the largest market for wound debridement products due to product innovation, rise in incidence of diabetes cases, increasing healthcare spending and growing aging population in this region. Asia is expected to show high growth rate in the wound debridement products market in next few years due increasing demand for better healthcare facilities, adoption of advanced wound debridement products, developing healthcare infrastructure and increasing patient’s population in the region.Increasing incidence of hard and heal wounds, growing aging population, rise in prevalence of chronic diseases, increasing adoption of debridement products and techniques and rise in patients population  are driving the market for wound debridement products. In addition, rise in demand for better healthcare, reimbursement policy, increasing healthcare expenditure and cost effectiveness of debridement products are driving the global market for wound debridement products. However, economic downturn is restraining for the growth of global wound debridement products market.’

Request for sample reports@ https://www.persistencemarketresearch.com/samples/3541

Growing demographics and economies in the developing countries such as India and China are expected to lead growth in wound debridement products market in Asia. In addition, increasing demand for wound bed preparation method, rise in popularity of wound care at home, advancement in debridement products and growing awareness about benefits of timely wound management are expected to offer new opportunities for global wound debridement products market. Demand for reducing hospital stay, rise in incidence of hard and heal wounds, increasing number of mergers and acquisitions, growing number of collaborations and partnerships and new products launches are some of the latest trends that have been observed in global wound debridement products market.  Some of the major companies operating in the global wound debridement products market are Advanced Medical Solutions Group plc, Coloplast A/S, ArthroCare Corporation and Misonix, Inc. In addition, some other companies operating in the global wound debridement products market are Derma Sciences, Inc., MediWound Ltd, PuriCore plc and Smith & Nephew Plc.

[persistencemarketresearchre-blog]

Global Market Study on Cleanroom Technology: Consumables to Witness Highest Growth by 2020

According to a new market report published by Persistence Market Research titled Global Market Study on Cleanroom Technology: Consumables to Witness Highest Growth by 2020, the global cleanroom technology market was valued at USD 3,156.0 million in 2014 and is expected to grow at a CAGR of 5.2% from 2014 to 2020 to reach an estimated value of USD 4,290.1 million by 2020. Cleanroom refers to an enclosed space constructed in such a manner so as to control the concentration of airborne particles such as particulates (dust, hair), chemicals (oil, grease), microorganisms (bacteria, fungus), and radiations. Additionally, temperature, humidity, pressure, electrostatic charge, magnetic flux, and other factors in cleanrooms can also be maintained as per the requirement.

]  Request for sample reports@ https://www.persistencemarketresearch.com/samples/3143  

Globally, the cleanroom technology market is witnessing significant growth due to growing regulatory concerns regarding the packaging, manufacturing, and processing of better quality products, and safety of the working personnel. Additionally, increasing demand for sterilized pharmaceutical formulations, and development of new biologics and its wide applications in the medical devices industry is driving the growth of the cleanroom technology market. However, factors such as lack of skilled professionals and high cost associated with the setting up and maintenance of cleanrooms are restraining the growth of the global market for cleanroom technology. The global cleanroom technology market was valued at USD 3,156.0 million in 2014 and is expected to reach USD 4,290.1 million by 2020, growing at a CAGR of 5.2%. Request for Methodology@   https://www.persistencemarketresearch.com/methodology/3143

North America is the largest segment in the global cleanroom technology market. This is due to technological advancements and growing applications of cleanroom technology in the region. The North American market for cleanroom technology was valued at USD 1,209.3 million in 2014 and is expected to reach USD 1,580.8 million by 2020, growing at a CAGR of 4.6%. In terms of type, cleanroom consumables are the fastest-growing segment. In terms of construction, standard/drywall cleanroom is the largest segment in the global cleanroom technology market. Cleanroom technology has wide applications in the pharmaceutical industry.

[persistencemarketresearchre-blog]

Global Market Study on Cranio Maxillofacial Implants

According to a new market report published by Persistence Market Research  “Global Market Study on Cranio Maxillofacial Implants: Asia to Witness Highest Growth by 2020” the global cranio maxillofacial implants market was valued at USD 1,044.7 million in 2014 and is expected to grow at a CAGR of 6.2% from 2014 to 2020, to reach an estimated value of USD 1,498.6 million in 2020. Cranio maxillofacial surgery refers to a procedure for treatment of a severe injury to the cranial and facial bones. Treatment of injured cranial and facial bones usually requires internal fixators such as plate and screw fixation systems, flap fixation devices, bone graft substitutes or others to fix the facial fracture. Globally, the cranio maxillofacial implants market is witnessing significant growth due to increasing incidence of facial fractures and emergence of new procedural techniques and positive clinical outcome. In addition, increased healthcare expenditure and lack of substitutes are driving the cranio maxillofacial implants market. However, various factors such as high cost of surgery and lack of awareness are restraining the growth of cranio maxillofacial implants market. In addition, double surgery and absence of health insurance in the developing countries are restraining the cranio maxillofacial implants market. The global cranio maxillofacial implants market is estimated at USD 1,044.7 million in 2014. It is likely to grow at a CAGR of 6.2% from 2014 to 2020 to reach USD 1,498.6 million in 2020.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/3120

North America, including the U.S. has the largest cranio maxillofacial implants market. Asia is the fastest growing cranio maxillofacial implants market. Some of the fastest growing markets for cranio maxillofacial implants devices are China, Japan and other countries in South East Asia and the Eastern Mediterranean.  North American market for cranio maxillofacial implants is estimated at USD 586.1 million in 2014 and is expected to reach USD 839.6 million in 2020, growing at a CAGR of 6.2% from 2014 to 2020. On the basis of the type of fixator, internal fixators have the largest market share in the cranio maxillofacial implants market and it is expected to grow at a CAGR of about 6.0% during 2014 – 2020. Various cranio maxillofacial implants companies are increasing their focus on manufacturing of internal fixators with bioabsorbable material. Market for bioabsorbable fixators is expected to grow at a CAGR of about 8.4% during 2014 – 2020.

Request for Methodology@  https://www.persistencemarketresearch.com/methodology/3120

DePuy Synthes, a Johnson & Johnson company, is a leading player in the global market for cranio maxillofacial implants, with a share of about 47.5% in 2013. Other major players of cranio maxillofacial implants market include Stryker Corporation, Zimmer Holdings, Inc. and others.

[persistencemarketresearchre-blog]

Type Diabetes Market: Type Diabetes Market

Diabetes refers to a group of metabolic disease characterized by high blood sugar level. Diabetes occurs due to inadequate secretion of insulin inside the pancreas. Some of the common symptoms for diabetes are frequent urination, excessive thirst, increased hunger, weight loss and tiredness. Type 1, type 2 and gestational diabetes are three types of diabetes. Type 1 diabetes is an autoimmune disease occurred due to high blood glucose level whereas, type 2 diabetes is a lifelong chronic diseases caused due to excess secretion of insulin inside the body. In type 1 diabetes, the immune system is activated against self-insulin producing cells. This results into low production of insulin and also disrupts blood glucose homeostasis. In type 1 diabetes, exposure to viral infection such as mumps and coxsackie viruses results into pancreas damage which results into low insulin secretion. Type 1 diabetes is highly prevalent in young people and children whereas type 2 diabetes is common type of diabetes. Some of the common symptoms for type 2 diabetes are overweight, high blood pressure and high triglycerides. Diabetes is treated with the help of insulin delivery devices and drugs. Diabetes diagnostic devices includes analog blood meter, test strips, lancets and lancing devices whereas, insulin delivery devices includes insulin syringe, insulin pump, insulin pen and insulin jet injectors. Severe problems such as blindness, kidney failure, coronary heart disease and strokes may result due to lack of proper treatment.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/3706

North America is dominating the global type 1 diabetes market due to rising prevalence of diabetes. The U.S. is dominating the North American diabetes market. Asia Pacific region is expected to show high growth rate due to rising aging population in coming five years.In recent time there is increased use of insulin delivery devices due to rising number of chronic diseases associated with diabetes. Rising awareness among people and technological advancement in insulin delivery devices are some of the key factors driving the growth of the global type 1 diabetes market. In addition, increasing government initiatives for diabetes control is also fuelling the growth of the global type 1 diabetes market. However, high cost of diagnosis and treatment is restraining the growth of the global type 1 diabetes market. In addition, unfavorable reimbursement policies are also inhibiting the growth of the global type 1 diabetes market.

Request for TOC@ https://www.persistencemarketresearch.com/toc/3706 Side effects associated with diabetes therapies could lead a challenge for the global type 1 diabetes market. Strong pipeline and development of molecules from newer class of diabetes drugs would be an opportunity for the growth of the global type 1 diabetes market. In addition, development of non-invasive diabetes diagnostics and drug delivery devices would also develop an opportunity for the growth of the global type 1 diabetes market. Increasing demand for artificial pancreas and home infusion therapy for diabetes treatment are some of the trend for the growth of the global type 1 diabetes market. Some of the major companies operating in the global type 1 diabetes market are Eli Lilly and Company, Astrazeneca Plc., B.Braun Melsungen AG, Novo Nordisk A/S, Sanofi-Aventis US, LLC, DiaVacs, Inc., XOMA Corp., Biodel, Inc. and Macrogenics, Inc.

[persistencemarketresearchre-blog]

Global Market Study on GMP Cell Banking Services: Mammalian Cell Type Segment Revenue Projected to Grow 3.2x by 2025 End as Compared to that in 2017

North America is estimated to hold a whopping 45.3% value share in the global GMP cell banking services market by the end of 2017 and will witness an increase of 231 basis points in market share by 2025 over 2017. The North America regional market will create absolute $ opportunity of US$ 23 Mn in 2018 over 2017. In a new report titled “GMP Cell Banking Services Market: Global Industry Analysis and Forecast, 2017–2025,” Persistence Market Research forecasts revenue from the North America market to grow 3.1x by 2025 end as compared to that in 2017. This will directly impact the global GMP cell banking services market, which will likely grow from US$ 346.6 Mn in 2017 to US$ 1,012.4 Mn by the end of 2025, translating into a CAGR of 14.3% during the eight year forecast period 2017 – 2025.Strategic industry consolidations and increase in demand for Ready-to-Use (RTU) Bioassay Banks is trending the global GMP cell banking services marketOne of the key objectives of the report is to identify the key trends governing the global GMP cell banking services market and present a clear picture of the various forces impacting the market at a micro and macro level. A sustained growth of the market can be attributed to macro-economic drivers such as increased public and private sector funding for disease research, which is expected to bring newer therapies to the market; high costs of clinical development; and various collaborative initiatives to identify therapies for difficult-to-treat illnesses.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/13735

On the supply side, an expansion of production facilities by key players to meet growing customer demand besides offering customized solutions based on specific customer needs (this involves strategic tie-ups between biopharmaceutical companies and cell banking service providers) are some of the factors likely to push the global GMP cell banking services market ahead in the coming years. The report also identifies certain demand side drivers boosting the market such as a growing number of biologics in development currently, limited in-house storage and testing capabilities and a rise in the demand for outsourcing and contract manufacturing.While the above growth factors are indicative of a mature market, Persistence Market Research identifies certain pull factors likely to restrain the market to a certain extent in the coming years. First off, the global GMP cell banking services market is highly fragmented with multiple vendors offering a variety of services – resulting in limited global reach. Besides, complexities in the production and manufacturing processes, a constantly evolving technology landscape, and inconsistent demand for services are likely to restrain revenue growth of the global GMP cell banking services market during the forecast period.Persistence Market Research predicts a large opportunity for key players in the fast growing Asia Pacific region. It must be noted that there has been a shift of R&D and technology investments in the healthcare industry from North America and Europe to Asia Pacific with developing APAC economies such as India offering increased scope for outsourcing of biotech projects owing to ample skilled and qualified manpower at optimal costs. Mammalian cell type segment to retain its pole position throughout the forecast periodAmong the cell type segments, the Mammalian segment was the dominant segment in 2016 and is expected to retain its dominance through 2025. From an estimated US$ 216 Mn in 2017 to a market valuation in excess of US$ 680 Mn by the end of the forecast period, the Mammalian segment will register the highest CAGR of 15.6% among the other cell type segments. The Microbial segment is the second most attractive cell type segment in the global GMP cell banking services market in terms of revenue. Registering a value CAGR of 12.9% between 2017 and 2025, the Microbial segment will hold the second position among the cell type segments of the global GMP cell banking services market.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/13735

Biopharmaceutical Companies will be the largest end users of GMP cell banking servicesAmong the end user segment of the global GMP cell banking services market, the Biopharmaceutical Companies segment will emerge the undisputed leader both in terms of market share (estimated to hold almost 69% share by 2017 end) and CAGR (an impressive 15.4% during 2017 – 2025). In comparison, the Contract Manufacturing Organizations segment will come a pale second, recording a market attractiveness index of 0.5 during the forecast period.

[persistencemarketresearchre-blog]

North America’s wound debridement products market to expand at a steady 6.9% CAGR throughout the forecast period 2016-2024.

Health risks of unattended wounds or undue exposure to infected tissues are becoming an alarming concern in the healthcare industry of North America. Ineffectiveness of conventional wound care products continues to impede the surgical improvement of patients being treated with infected diseases. In North America, growing expenditure on healthcare facilities and invasive surgeries compels medical organizations to improve recuperation processes such as tissue regeneration through the use of wound debridement products. According to a recent study undertaken by Persistence Market Research, total market revenues procured by sales of wound debridement products in North America are estimated to reach US$ 307.8 million by the end of 2024.Persistence Market Research’s report, titled “Wound Debridement Products Market: North America Industry Analysis & Forecast, 2016-2024,” includes key findings that indicate

North America’s wound debridement products market

to expand at a steady 6.9% CAGR throughout the forecast period 2016-2024. According to the report, an estimated US$ 171.8 million revenues have been attained in North America through wound debridement products sales in 2015. Over the projection period, a majority of North America’s wound debridement products revenues will be accounted by the US healthcare sector as Canada is anticipated to attribute just over 10% of the gross market value.Top Research Findings on North America’s Wound Debridement Products Market

In US, surging need for the application of wound debridement products in treatment of chronic ulcers is expected to account for the highest revenue share through 2024.

By the end of 2024, the US wound debridement products market is projected to be valued over US$ 250 million.

On the other hand, the wound debridement products revenues attained from Canada are expected to exhibit an estimated US$ 1.3 million increment in terms of revenues, between 2016 and 2017.

Availability of a vast patient pool in North America serves as a favorable quotient for the growth of its wound debridement products market.

Nevertheless, complications arising from Medical adhesive-related skin injury (MARSI) is projected to inhibit the growth in demand for wound debridement products in North America.

Request for sample reports@

https://www.persistencemarketresearch.com/samples/12967

The growth of North America’s wound debridement products market has been analyzed on the basis of various types of products, considering their effectiveness, affordability and preference as key determinants of growth. In 2016 and beyond, mechanical debridement pads and traditional wound debridement devices will collective account for nearly 50% of the market revenues. Meanwhile, the market value share of surgical wound debridement devices is projected to drop from nearly 20% in 2016 to just over 15% by the end of 2024.

Request for Methodology@

https://www.persistencemarketresearch.com/methodology/12967

Throughout the forecast period, hospitals will retain as the dominant end-users of wound debridement products in North America. By the end of 2024, revenues procured from wound debridement products sales to hospitals will be nearly 50% of the gross estimated revenues. ASCs and specialized clinics are expected to collectively garner over US$ 100 million in revenues by 2024-end, while wound debridement products sales accounted by North American nursing facilities will expand at a moderate CAGR of 4.6%. Increasing incidences of chronic ulcers in North America is projected to instrument the growth in demand for wound debridement products in hospitals. Revenues generated from the wound debridement products sales in chronic ulcers treatment across North American hospitals are expected to expand at an impressive 8.2% CAGR over the forecast period.

[persistencemarketresearchre-blog]

Technological Advancements to Play a Key Role in Growth of   Decyl Oleate Market

Decyl oleate is industrially produced by the esterification of fatty alcohols and oleic acid, which is used as an emollient in the composition of cosmetics, hair care, and skin care products. The major application of decyl oleate is in the personal care and pharmaceuticals segment. Growth in the demand for decyl oleate is largely contributed by the increase in skin care consciousness among people. Decyl oleate is produced from two sources namely plants and animals. A new research report by Persistence Market Research titled ‘Decyl Oleate Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025’ provides deep insights on the global decyl oleate market. According to the market analysis, the global

decyl oleate market

is expected to reach a market valuation of over US$ 900 Mn by the end of 2025. This reflects a CAGR of 3.6% during the forecast period 2017-2025. Among the different types of decyl oleate based on source, there is comparatively more demand for plant based decyl oleate owing to consumers’ increasing preference for natural ingredient based products. Plant based decyl oleate also has other associated benefits such as ease of availability, low production cost, and environment friendly nature.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/17719

Global Decyl Oleate Market: DriversRapid urbanization in many regions has helped people gain considerable disposable income. People are now spending more on their personal care. This has led to an increase in demand for personal care products, in turn increasing the demand for decyl oleate, which is a key ingredient in these products. The cosmetics and beauty market is also growing with a rise in the number of appearance conscious people. This is also expected to benefit the global decyl oleate market.However availability of decyl oleate substitutes in the market may have a negative impact on market revenue growth. Cosmetics and beauty care manufacturers are preferring other substitutes as an emollient in their products. This could hamper the sales of decyl oleate over the forecast period.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/17719

Global Decyl Oleate Market: Segmental Highlights

Based on region, Asia Pacific is expected to be the dominating regional market with a higher market value during the forecast period. APAC is expected to reach a value of over US$ 340 Mn by the end of 2025. The region is also expected to witness the highest growth rate, with a CAGR of 4.0% during 2017 – 2025.

Based on source type, plant based decyl oleate is expected to lead the market in terms of value during the forecast period. Animal based decyl oleate is expected to register a CAGR of over 2.9% during 2017-2025.

Based on application, the personal care segment is anticipated to show the maximum demand and grow at a higher rate as compared to the pharmaceuticals segment. The pharmaceuticals segment is also expected to witness progressive growth during the forecast period.

[persistencemarketresearchre-blog]

Technological Advancements to Play a Key Role in Growth of  Shoulder ReplacementMarket

The shoulder replacement market is expected to witness robust growth and is anticipated to grow across important regional markets in the coming years. Persistence Market Research has captured the rhythm of the global

shoulder replacement market

and has represented it in an insights format in a new research publication titled “Shoulder Replacement Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” This research study focuses on the impact of drivers, challenges, restraints, trends and opportunities on the global shoulder replacement market during the period 2017 to 2025. A detailed segmentation is covered in the report, which helps in estimating the value and volume projections during the period 2017 to 2025.

Request for sample reports@ https://www.persistencemarketresearch.com/samples/17611

Global Shoulder Replacement Market: Factors Impacting Growth During 2017 to 2025The main factors boosting the growth of the global shoulder replacement market are – the rising number of surgeries, the technological advancements, increasing disposable income, increasing focus on cost efficiency, transparency of data, increased strategic alliances to initiate knowledge sharing, and the rising life expectancy of the population. However, the market is not devoid of hurdles. Delayed tendering and reimbursement streamlining, poor operational environment, higher cost concerns, and increasing import duties on healthcare products could pose a threat to the growth of the global shoulder replacement market in the coming years.Global Shoulder Replacement Market: Segmental AnalysisThe global shoulder replacement market is segmented on the basis of implant type, end user and region. With respect to implant type, it is further segmented into anatomical shoulder prosthesis and reverse shoulder prosthesis. By end user, the market is segmented into hospitals, ambulatory surgical centers and orthopedic clinics. By region, the global shoulder replacement market is segmented into North America, Latin America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA).

The anatomical shoulder prosthesis segment is expected to dominate the global shoulder replacement market by implant type, and is anticipated to register a CAGR of 8.1% during the period of forecast; the segment will show dominance by reaching a market value of about US$ 2 Bn

By region, North America is expected to dominate the global shoulder replacement market by registering high growth throughout the period of forecast as compared to other regions. Following North America, Asia Pacific also shows higher potential and is set to witness a CAGR of 7.4% during the forecast period

The hospitals segment is expected to dominate the global shoulder replacement market by end user to reflect a market value of more than US$ 1.6 Bn by the end of 2025 and is poised to grow at the highest growth rate during the forecast period. Following this segment, the ambulatory surgical centers segment also shows higher growth rate and is poised to register a CAGR of 7.8% during the forecast period

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/17611

Global Shoulder Replacement Market: ForecastAccording to Persistence Market Research, the global shoulder replacement market is expected to record a revenue growth of US$ 2.9 Bn by the end of 2025 from about US$ 1.5 Mn in 2017, reflecting a CAGR of 7.8% during the period of assessment.